Pathology Laboratories Market - Databook 2025 to 2034

The global pathology laboratories market size was estimated at USD 380.88 billion in 2024 and is projected to be worth around USD 818.4 billion by 2034, growing at a CAGR of 7.94% from 2025 to 2034.

Highlights of the Pathology Laboratories Market

• North America dominated the global pathology laboratories market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By type, the hospital-based segment holds a dominant presence in the pathology laboratories market in 2024.
• By type, the diagnostic chains segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By testing service, the clinical tests & general physiological segment holds a dominant presence in the pathology laboratories market in 2024.
• By testing service, the esoteric tests segment is set to experience the fastest rate of market growth from 2025 to 2034.
• By end-use, the physician referrals segment holds a dominant presence in the pathology laboratories market in 2024.
• By end-use, the corporate segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

The pathology laboratories market is becoming progressively vital as healthcare systems worldwide shift from reactive to preventive and proactive care models. The growing focus on early detection, specialized diagnostics, and continuous monitoring, thus, is due to the rising incidence of cardiovascular problems, cancer, infectious diseases, and diabetes. Artificial Intelligence (AI), cloud-based laboratory information management systems (LIMS), and digital pathology, adapt to the fate of data analytics and pathological diagnosis. Digital transformation supports labs to enhance efficiency, lessen turnaround times, and implement remote pathology services that are mainly important in underserved or rural areas.

Pathology Laboratories Market: Stats and Figures

• There are 76 CAP 15189-accredited laboratories in the United States as of 2025.
• As of 2020, the United States was home to 336,642 medical and pathology laboratory scientists.

Industry Leader Announcements

• Mark Schroeder, EVP and President, Diagnostics Laboratories and Chief Operations Officer, Labcorp

"By integrating BioReference Health’s oncology and related clinical testing services into our portfolio, we're providing greater access to our world-class services to patients, physicians, and healthcare providers across the country,” said Mark Schroeder, EVP and President, Diagnostics Laboratories and Chief Operations Officer, Labcorp. “This acquisition also aligns with our strategy to lead in oncology and reinforces our commitment to advancing cancer care through innovative and comprehensive laboratory services. We look forward to welcoming our new colleagues and working together to deliver even greater value to the healthcare community."

How AI Has Benefitted the Pathology Laboratories Market

AI in medical diagnostics has mainly been developed to enhance effectiveness and efficiency in clinical caregiving. One of the greatest benefits of AI in pathology is in the precision image-processing, and that too at a greater speed. Besides, it assists in determining biomarkers at an early stage of testing, thus saving pathologists time for determining samples. Further, with the advancement of brightfield and virtualization, fluorescent slide scanners are assisting pathologists in predicting hidden issues. Processes such as immunohistochemistry and digital histopathology are aiding medical providers in their routine jobs.

Geographical Insights

The pathology laboratories market is experiencing significant growth, with North America maintaining its position as the dominant region while Europe emerges as the rapidly growing market. The Asia Pacific region is projected to be the fastest-growing in the pathology laboratories market during the forecast period.

North America

North America dominated the global pathology laboratories market in 2024. High acceptance rates of the latest diagnostic technologies, which include digital pathology and AI-derived tools, are vital factors. The region's well-known healthcare infrastructure, as well as a strong regulatory framework, led to its dominance. The growing target of personalized medicine also drives the demand for accurate and specialized diagnostic testing, thus accelerating the market.

Europe

Europe is experiencing rapid growth in the pathology laboratories market during the forecast period. The rising proportion of older individuals in Europe is contributing to a higher requirement for diagnostic services. Advancements in diagnostic technologies, like next-generation sequencing and digital pathology, improve the efficiency and accuracy of pathology testing.

Asia Pacific

Asia Pacific is projected to be the fastest-growing pathology laboratory market during the forecast period. Raised investment in the healthcare framework and expanding acceptance of healthcare services are driving the need for pathology services. Digital pathology, AI-derived diagnostics, and automation enhance the accuracy, speed, and efficiency of pathology testing.

Recent Developments

• In August 2024, Redcliffe Labs, an omnichannel diagnostics service manufacturer, expanded its footprint in Delhi NCR by demonstrating two new diagnostic laboratories. The firm informed that these additions highlight Redcliffe Labs' commitment to improving the accessibility of reliable as well as high-quality diagnostic services across the region.
• In March 2024, Metropolis Healthcare Limited started a new diagnostic laboratory facility in Malegaon, Maharashtra (India). This facility has the ability to process 3,000 samples per month.

Competitive Landscape

The pathology laboratories market is enduring substantial expansion, driven by factors such as rising chronic disorder prevalence, an older population, and developments in healthcare infrastructure.

• Company Name: Spectra Laboratories
• Year of Incorporation: 1983
• Headquarters: Milpitas, California

Spectra Laboratories, a subsidiary of Fresenius Medical Care North America, faces competition in the renal-specific laboratory testing market from other large diagnostic firms and specialized laboratories.

• Company Name: Eurofins Scientific
• Year of Incorporation: 1987
• Headquarters: Luxembourg

Eurofins Scientific faces competition from several firms across its numerous business areas. Eurofins also targets competition from various smaller, specialized firms within specific niche markets, like environmental testing, food testing, and agroscience services.

• Company Name: Sonic Healthcare Limited
• Year of Incorporation: 1987
• Headquarters: Sydney, Australia

Sonic Healthcare aims to compete with various global and regional key players in the pathology sector and laboratory medicine. The competitive landscape is molded by factors like pricing pressures from payers, the demand for continuous investment in technology, and the potency for consolidation amongst healthcare providers.